Published in Nucleic Acids Res on November 07, 2008
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet (2009) 13.03
Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature (2011) 2.93
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat Med (2012) 2.66
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science (2013) 2.34
Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res (2012) 2.08
OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7. Nat Immunol (2013) 1.87
Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling. Cancer Cell (2010) 1.78
Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One (2009) 1.61
The interferon stimulated gene 54 promotes apoptosis. J Biol Chem (2010) 1.58
The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J Virol (2010) 1.47
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD. Blood (2014) 1.44
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine. Oncotarget (2013) 1.44
Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol Rev (2012) 1.38
Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling. PLoS One (2013) 1.35
HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood (2011) 1.33
Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro. Respir Res (2010) 1.26
A genome-wide RNAi screen reveals that mRNA decapping restricts bunyaviral replication by limiting the pools of Dcp2-accessible targets for cap-snatching. Genes Dev (2013) 1.09
Antitumour actions of interferons: implications for cancer therapy. Nat Rev Cancer (2016) 1.08
Multifaceted activities of type I interferon are revealed by a receptor antagonist. Sci Signal (2014) 1.04
Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog (2012) 1.03
Plasmacytoid dendritic cells and C1q differentially regulate inflammatory gene induction by lupus immune complexes. J Immunol (2011) 1.00
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med (2017) 0.98
A Comprehensive Profile of ChIP-Seq-Based STAT1 Target Genes Suggests the Complexity of STAT1-Mediated Gene Regulatory Mechanisms. Gene Regul Syst Bio (2013) 0.97
IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells. PLoS One (2011) 0.96
Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ. PLoS Pathog (2011) 0.95
RNAimmuno: a database of the nonspecific immunological effects of RNA interference and microRNA reagents. RNA (2012) 0.94
Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease. Respir Res (2013) 0.91
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections. J Interferon Cytokine Res (2015) 0.90
Cellular transcriptional profiling in human lung epithelial cells infected by different subtypes of influenza A viruses reveals an overall down-regulation of the host p53 pathway. Virol J (2011) 0.89
Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms. PLoS Pathog (2015) 0.87
The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells. PLoS Pathog (2012) 0.87
Interferons as inducers of apoptosis in malignant cells. J Interferon Cytokine Res (2013) 0.87
Evidence for a different susceptibility of primate lentiviruses to type I interferons. J Virol (2012) 0.87
Bridging the species divide: transgenic mice humanized for type-I interferon response. PLoS One (2014) 0.87
Permissive and restricted virus infection of murine embryonic stem cells. J Gen Virol (2012) 0.86
IFNs Modify the Proteome of Legionella-Containing Vacuoles and Restrict Infection Via IRG1-Derived Itaconic Acid. PLoS Pathog (2016) 0.86
Activation of invariant NK T cells in periodontitis lesions. J Immunol (2013) 0.85
Type I interferon dysregulation and neurological disease. Nat Rev Neurol (2015) 0.84
Global secretome characterization of herpes simplex virus 1-infected human primary macrophages. J Virol (2012) 0.83
Identification of STAT2 serine 287 as a novel regulatory phosphorylation site in type I interferon-induced cellular responses. J Biol Chem (2012) 0.82
Type I interferon receptor-independent and -dependent host transcriptional responses to mouse hepatitis coronavirus infection in vivo. BMC Genomics (2009) 0.82
Oligomerization and GTP-binding Requirements of MxA for Viral Target Recognition and Antiviral Activity against Influenza A Virus. J Biol Chem (2015) 0.82
Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon beta. PLoS One (2013) 0.82
An integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clones. BMC Genomics (2011) 0.82
The C-terminal sequence of IFITM1 regulates its anti-HIV-1 activity. PLoS One (2015) 0.81
Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmatics. BMC Med Genomics (2012) 0.81
Innate Immune Signaling Activated by MDR Bacteria in the Airway. Physiol Rev (2016) 0.81
Neuronal c-Abl activation leads to induction of cell cycle and interferon signaling pathways. J Neuroinflammation (2012) 0.80
E2F/Rb Family Proteins Mediate Interferon Induced Repression of Adenovirus Immediate Early Transcription to Promote Persistent Viral Infection. PLoS Pathog (2016) 0.80
Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs. Clin Exp Metastasis (2010) 0.79
IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent. PLoS One (2013) 0.79
Excess type I interferon signaling in the mouse seminiferous tubules leads to germ cell loss and sterility. J Biol Chem (2011) 0.79
CD8(+) lymphocytes suppress human immunodeficiency virus 1 replication by secreting type I interferons. J Interferon Cytokine Res (2013) 0.79
Use of transcriptional profiling to delineate the initial response of mice to intravaginal herpes simplex virus type 2 infection. Viral Immunol (2013) 0.78
Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine. Sci Rep (2016) 0.78
Monosodium urate activates Src/Pyk2/PI3 kinase and cathepsin dependent unconventional protein secretion from human primary macrophages. Mol Cell Proteomics (2013) 0.78
Bugs in the system. Immunol Rev (2013) 0.78
Systems-biology approaches to discover anti-viral effectors of the human innate immune response. Viruses (2011) 0.78
TDP-1, the Caenorhabditis elegans ortholog of TDP-43, limits the accumulation of double-stranded RNA. EMBO J (2014) 0.77
Suppression of soluble T cell-associated proteins by an anti-interferon-α monoclonal antibody in adult patients with dermatomyositis or polymyositis. Rheumatology (Oxford) (2013) 0.77
Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies. J Exp Pharmacol (2010) 0.77
Molecular Mechanisms Governing Differential Type I Interferons Signaling. J Biol Chem (2017) 0.76
Assessment of mTOR-Dependent Translational Regulation of Interferon Stimulated Genes. PLoS One (2015) 0.76
Type I interferons as regulators of human antigen presenting cell functions. Toxins (Basel) (2014) 0.76
Identification of immunomodulatory signatures induced by american ginseng in murine immune cells. Evid Based Complement Alternat Med (2013) 0.75
Tissue and time specific expression pattern of interferon regulated genes in the chicken. BMC Genomics (2017) 0.75
Activation of IRF1 in Human Adipocytes Leads to Phenotypes Associated with Metabolic Disease. Stem Cell Reports (2017) 0.75
Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9. J Biol Chem (2017) 0.75
Identification of simple sequence repeat biomarkers through cross-species comparison in a tag cloud representation. Biomed Res Int (2014) 0.75
The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond. Front Immunol (2017) 0.75
Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis. Int J Mol Sci (2016) 0.75
Passive broad-spectrum influenza immunoprophylaxis. Influenza Res Treat (2014) 0.75
A Well-Controlled Experimental System to Study Interactions of Cytotoxic T Lymphocytes with Tumor Cells. Front Immunol (2016) 0.75
In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor. Bioengineering (Basel) (2017) 0.75
IFNAR2-dependent gene expression profile induced by IFN-α in Pteropus alecto bat cells and impact of IFNAR2 knockout on virus infection. PLoS One (2017) 0.75
Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma. Oncogene (2017) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
The Bioperl toolkit: Perl modules for the life sciences. Genome Res (2002) 58.63
A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A (2004) 44.81
How cells respond to interferons. Annu Rev Biochem (1998) 24.27
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2007) 22.53
TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res (2006) 22.20
Ensembl 2008. Nucleic Acids Res (2007) 20.67
The universal protein resource (UniProt). Nucleic Acids Res (2007) 16.33
DNA binding sites: representation and discovery. Bioinformatics (2000) 16.01
High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res (2008) 13.51
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 13.39
Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol (2005) 11.57
Interferon-inducible antiviral effectors. Nat Rev Immunol (2008) 9.68
Interferons and their actions. Annu Rev Biochem (1987) 8.36
The vertebrate genome annotation (Vega) database. Nucleic Acids Res (2007) 7.53
A gene network for navigating the literature. Nat Genet (2004) 6.43
Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol (2001) 6.19
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology (2006) 6.16
Matrix2png: a utility for visualizing matrix data. Bioinformatics (2003) 5.31
IDconverter and IDClight: conversion and annotation of gene and protein IDs. BMC Bioinformatics (2007) 4.17
Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol (2002) 3.64
Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology (2006) 3.46
Cytokine therapeutics: lessons from interferon alpha. Proc Natl Acad Sci U S A (1994) 2.90
Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics. Hepatology (2006) 2.69
Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci U S A (2001) 2.56
Type I interferon receptors: biochemistry and biological functions. J Biol Chem (2007) 2.14
Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev (2005) 2.01
What's in a name? Genome Biol (2002) 2.00
Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro. J Interferon Cytokine Res (2004) 1.98
Stat1-independent regulation of gene expression in response to IFN-gamma. Proc Natl Acad Sci U S A (2001) 1.96
Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol (2007) 1.87
Transcription Regulatory Regions Database (TRRD): its status in 2002. Nucleic Acids Res (2002) 1.82
Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2. J Interferon Cytokine Res (2003) 1.82
The interferon in TLR signaling: more than just antiviral. Trends Immunol (2003) 1.77
Differential gene induction by type I and type II interferons and their combination. J Interferon Cytokine Res (2006) 1.61
The interferon-stimulated genes: targets of direct signaling by interferons, double-stranded RNA, and viruses. Curr Top Microbiol Immunol (2007) 1.56
Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry. J Interferon Cytokine Res (2002) 1.55
Novel interferon-beta-induced gene expression in peripheral blood cells. J Leukoc Biol (2007) 1.45
Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J Immunol (2003) 1.43
The role of type I interferons in TLR responses. Immunol Cell Biol (2007) 1.38
Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy. J Neurol Sci (2007) 1.31
Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression. Proc Natl Acad Sci U S A (2005) 1.25
Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays. J Biol Chem (2002) 1.20
Genomic effects of IFN-beta in multiple sclerosis patients. J Immunol (2003) 1.18
System-based proteomic analysis of the interferon response in human liver cells. Genome Biol (2004) 1.09
STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha. Cancer Immunol Immunother (2007) 1.03
Identification of genes in the ovine endometrium regulated by interferon tau independent of signal transducer and activator of transcription 1. Endocrinology (2003) 0.94
Purification of recombinant human interferon-epsilon and oligonucleotide microarray analysis of interferon-epsilon-regulated genes. Protein Expr Purif (2006) 0.91
Targeting interferon-alpha: a promising approach for systemic lupus erythematosus therapy. Lupus (2004) 0.89
Regulation of gene expression in mouse trophoblast cells by interferon-gamma. Placenta (2007) 0.88
Identification of GAS-dependent interferon-sensitive target genes whose transcription is STAT2-dependent but ISGF3-independent. FEBS J (2006) 0.86
Functional annotation of IFN-alpha-stimulated gene expression profiles from sensitive and resistant renal cell carcinoma cell lines. J Interferon Cytokine Res (2006) 0.86
A microarray analysis for genes regulated by interferon-tau in ovine luminal epithelial cells. Reproduction (2007) 0.85
REFINEMENT: a search framework for the identification of interferon-responsive elements in DNA sequences--a case study with ISRE and GAS. Comput Biol Chem (2006) 0.82
Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol (2003) 12.34
Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol (2006) 3.94
STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest (2008) 2.95
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat Med (2012) 2.66
Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J Interferon Cytokine Res (2006) 2.56
Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res (2011) 2.39
Type I interferon receptors: biochemistry and biological functions. J Biol Chem (2007) 2.14
Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res (2012) 2.08
Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat Immunol (2005) 2.01
GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J Leukoc Biol (2009) 2.00
Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell Microbiol (2009) 1.87
Interferon-ε protects the female reproductive tract from viral and bacterial infection. Science (2013) 1.73
Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells. EMBO J (2002) 1.73
Type I-IFNs control GVHD and GVL responses after transplantation. Blood (2011) 1.54
Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation. EMBO J (2005) 1.52
The ETS transcription factor GABPalpha is essential for early embryogenesis. Mol Cell Biol (2004) 1.46
Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1. Nat Immunol (2013) 1.41
Functional crosstalk between type I and II interferon through the regulated expression of STAT1. PLoS Biol (2010) 1.40
IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. J Immunol (2010) 1.39
The role of type I interferons in TLR responses. Immunol Cell Biol (2007) 1.38
Characterization of the type I interferon locus and identification of novel genes. Genomics (2004) 1.36
MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. J Biol Chem (2009) 1.34
Mal interacts with tumor necrosis factor receptor-associated factor (TRAF)-6 to mediate NF-kappaB activation by toll-like receptor (TLR)-2 and TLR4. J Biol Chem (2004) 1.33
Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2. J Biol Chem (2011) 1.17
Systems biology of interferon responses. J Interferon Cytokine Res (2011) 1.11
Macrophage activation and differentiation signals regulate schlafen-4 gene expression: evidence for Schlafen-4 as a modulator of myelopoiesis. PLoS One (2011) 1.08
Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res Ther (2009) 1.07
Cutting edge: pulmonary Legionella pneumophila is controlled by plasmacytoid dendritic cells but not type I IFN. J Immunol (2010) 1.00
Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta. Bone (2006) 1.00
Potential contribution of NF-kappaB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemia-reperfusion injury. Stroke (2006) 0.99
An imbalance in antioxidant defense affects cellular function: the pathophysiological consequences of a reduction in antioxidant defense in the glutathione peroxidase-1 (Gpx1) knockout mouse. Redox Rep (2003) 0.98
A major site of expression of the ets transcription factor Elf5 is epithelia of exocrine glands. Histochem Cell Biol (2004) 0.97
A conserved IFN-alpha receptor tyrosine motif directs the biological response to type I IFNs. J Immunol (2008) 0.96
Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity. J Clin Invest (2014) 0.96
Ets2 is expressed during morphogenesis of the somite and limb in the mouse embryo. Mech Dev (2002) 0.95
Toll-like receptors as interferon-regulated genes and their role in disease. J Interferon Cytokine Res (2011) 0.94
The role of Ets2 transcription factor in the induction of microRNA-155 (miR-155) by lipopolysaccharide and its targeting by interleukin-10. J Biol Chem (2013) 0.93
TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice. Gastroenterology (2007) 0.92
Neonatal calyceal dilation and renal fibrosis resulting from loss of Adamts-1 in mouse kidney is due to a developmental dysgenesis. Nephrol Dial Transplant (2004) 0.90
The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol (2008) 0.88
The genomic profile of the cerebral cortex after closed head injury in mice: effects of minocycline. J Neural Transm (Vienna) (2008) 0.87
Characterization and transcriptional analysis of the mouse Chromosome 16 cytokine receptor gene cluster. Mamm Genome (2003) 0.86
Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing post-ischemic microvascular perfusion. J Neurochem (2008) 0.86
Targeting of the ETS factor GABPalpha disrupts neuromuscular junction synaptic function. Mol Cell Biol (2007) 0.86
Overview. Type I interferons as primers, activators and inhibitors of innate and adaptive immune responses. Immunol Cell Biol (2012) 0.85
Tissue-specific overexpression of the HSA21 gene GABPalpha: implications for DS. Biochim Biophys Acta (2004) 0.84
LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling. Immunol Cell Biol (2011) 0.84
Akt phosphorylation and NFkappaB activation are counterregulated under conditions of oxidative stress. Exp Cell Res (2004) 0.82
Interferons as biomarkers and effectors: lessons learned from animal models. Biomark Med (2012) 0.81
Helicobacter pylori VacA suppresses Lactobacillus acidophilus-induced interferon beta signaling in macrophages via alterations in the endocytic pathway. MBio (2013) 0.81
A human CD2 minigene directs CRE-mediated recombination in T cells in vivo. Genesis (2002) 0.81
RNA-eXpress annotates novel transcript features in RNA-seq data. Bioinformatics (2013) 0.81
Multiple regions within the promoter of the murine Ifnar-2 gene confer basal and inducible expression. Biochem J (2002) 0.80
Mitochondrially localised MUL1 is a novel modulator of antiviral signaling. Immunol Cell Biol (2013) 0.80
The early monocytic response to cytomegalovirus infection is MyD88 dependent but occurs independently of common inflammatory cytokine signals. Eur J Immunol (2013) 0.79
The Ets transcription factor ELF5 functions as a tumor suppressor in the kidney. Twin Res Hum Genet (2011) 0.79
Identification and expression analysis of alternative transcripts of the mouse GA-binding protein (Gabp) subunits alpha and beta1. Gene (2004) 0.78
Constitutive activation of gp130 leads to neuroendocrine differentiation in vitro and in vivo. Prostate (2005) 0.78
Non-essential role for TLR2 and its signaling adaptor Mal/TIRAP in preserving normal lung architecture in mice. PLoS One (2013) 0.78
Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection. Eur J Immunol (2014) 0.77
CpG pretreatment enhances antiviral T-cell immunity against cytomegalovirus. Blood (2013) 0.77
The role of Type I interferons in immunoregulation of breast cancer metastasis to the bone. Oncoimmunology (2013) 0.77
Ultraviolet-induced apoptosis in embryonic stem cells in vitro. Methods Mol Biol (2006) 0.76
Soluble IFN receptor potentiates in vivo type I IFN signaling and exacerbates TLR4-mediated septic shock. J Immunol (2014) 0.76
Endogenous interferon-alpha production by differentiating human monocytes regulates expression and function of the IL-2/IL-4 receptor gamma chain. Cytokine (2002) 0.76
Transcript profiling of Elf5+/- mammary glands during pregnancy identifies novel targets of Elf5. PLoS One (2010) 0.76
Comparison of mice born after intracytoplasmic sperm injection with in vitro fertilization and natural mating. Mol Reprod Dev (2007) 0.75
Chemokine receptor CCR5 is not required for development of experimental autoimmune gastritis. Clin Immunol (2003) 0.75